Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...

If you missed Oppenheimer in IMAX you can get another chance to see it this weekend with a one-week USA and Canada rerelease ...

Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...

Oppenheimer analyst Matthew Biegler says Olema Oncology (OLMA) published a revised corporate deck today which included an update from the ...

Tactile Systems Technology, Inc. ("Tactile Medical”; the "Company”) (Nasdaq: TCMD), a medical technology company providing ...

Christopher Nolan's Oppenheimer returned to theaters and is set to overtake Zack Snyder's Batman v. Superman as it climbs toward $1 billion.

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...

Oppenheimer Asset Management Inc. decreased its position in Affirm Holdings, Inc. (NASDAQ:AFRM – Free Report) by 22.8% in the ...

But there was lone Wall Street bear, BCA Research’s chief global strategist Peter Berezin, whose year-end S&P 500 SPX target ...

The ending of Apple TV+ thriller Prime Target explained, including if Leo Woodall’s brilliant mathematician survives his ordeal.

Okta (NASDAQ:OKTA – Free Report) had its price target upped by Oppenheimer from $125.00 to $135.00 in a research note issued ...